logo

Artificial Intelligence (AI) In Pharmaceutical Market Share

Statistics for the 2023 & 2024 Artificial Intelligence (AI) In Pharmaceutical market share, created by Mordor Intelligence™ Industry Reports. Artificial Intelligence (AI) In Pharmaceutical share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Healthcare IT Research AI in Pharma Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Artificial Intelligence (AI) In Pharmaceutical Industry

The artificial intelligence in the pharmaceutical market is fragmented in nature. In the current pharmaceutical market, the use of artificial intelligence (AI) has become increasingly prevalent, with a number of global players focusing on differentiating themselves in a highly competitive space. Also, there has been a recent influx of new market entrants rapidly gaining traction. Overall, competitive rivalry within the industry is expected to remain high during the forecast period.

Some of the major players in the AI pharmaceutical market include Alphabet Inc. (Isomorphic Labs), Atomwise Inc., BenevolentAI, BioSymetrics, Cloud Pharmaceuticals Inc., Deep Genomics, Deargen Inc., Euretos, Exscientia, Insilico Medicine, Cyclica Inc., and InveniAI LLC.

Artificial Intelligence (AI) In Pharmaceutical Market Leaders

  1. Deep Genomics

  2. Euretos

  3. Exscientia

  4. Insilico Medicine

  5. Alphabet Inc. (Isomorphic Labs)

*Disclaimer: Major Players sorted in no particular order

Artificial Intelligence (AI) In Pharmaceutical Market Concentration

AI in Pharma Market Report Snapshots

Artificial Intelligence in Pharmaceutical Industry Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)